PSMA放射引导手术在前列腺癌淋巴结转移检测中的2期研究
这项2期前瞻性研究纳入82例淋巴结侵犯风险>5%的局限性前列腺癌患者,评估PSMA放射引导手术在机器人辅助根治性前列腺切除及扩大盆腔淋巴结清扫中的可行性和准确性。62例完成研究,PSMA-RGS较术前PSMA PET额外识别2例pN1高危患者,但每患者分析PPV较低(50% vs 70%),NPV相似(83% vs 83%)。结论认为PSMA-RGS可发现PSMA PET遗漏的pN1患者并扩展清扫模板,但NPV不足以避免ePLND。
要点
- PSMA-RGS在PSMA PET基础上额外识别2例pN1高危前列腺癌患者。
- 每患者分析PSMA-RGS的PPV为50%低于PSMA PET的70%,NPV均为83%。
- miN1患者每区域分析PSMA-RGS的PPV和NPV均高于PSMA PET。
核心结论
- PSMA-RGS可识别术前PSMA PET遗漏的pN1高危前列腺癌患者,并扩展miN1患者的ePLND模板。
- PSMA-RGS的NPV不足以在LNI风险>5%且术中扫描阴性的患者中避免ePLND。
研究设计与样本
- 2期前瞻性研究(NCT04832958),纳入82例局限性前列腺癌且LNI风险>5%的患者。
- 所有患者术前行PSMA PET,术前一天静脉注射[99mTc]Tc-PSMA-I&S后行SPECT/CT,术中行PSMA-RGS。
- 62例完成全部研究流程并纳入最终分析。
主要发现
- 中位失血量和住院时间分别为50 ml和4天。
- 示踪剂给药后无不良事件,术中无并发症记录。
- 30天内4例发生Clavien-Dindo 3级并发症。
- 每患者分析中,PSMA-RGS较术前PSMA PET额外识别2例pN1高危患者,PPV为50% vs 70%,NPV均为83%。
- miN1患者每区域分析中,PSMA-RGS的PPV为55% vs 42%,NPV为85% vs 81%。
临床怎么用
- 在高危前列腺癌患者RARP+ePLND中,可考虑使用PSMA-RGS辅助识别PSMA PET遗漏的淋巴结转移。
- 对miN1患者,PSMA-RGS可扩展ePLND模板以覆盖PSMA PET低估的淋巴结负荷。
- LNI风险>5%且PSMA-RGS阴性的患者不应据此省略ePLND。
局限性
- 82例入组中仅62例完成全部研究流程并纳入最终分析。
- 本研究为单臂2期研究,未报告随机对照比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report the results of a prospective trial aimed at describing the feasibility and accuracy of prostate-specific membrane antigen (PSMA) radio-guided surgery (RGS) during robot-assisted radical prostatectomy (RARP) with extended pelvic lymph node dissection (ePLND) in patients with prostate cancer (PCa). This was a phase 2 study (NCT04832958) that enrolled 82 patients with localized PCa and a lymph node invasion (LNI) risk >5%. All patients underwent preoperative PSMA positron emission tomography (PET). [99mTc]Tc-PSMA-I&S was administered intravenously the day before surgery, followed by single-photon emission computed tomography/computed tomography. Side effects, perioperative outcomes, and the performance characteristics of PSMA-RGS for LNI detection were measured. A total of 62 patients completed all study procedures and were included in the final analyses. Median blood loss and length of stay were 50 ml and 4 d, respectively. No adverse events after tracer administration or intraoperative complications were recorded. Four patients experienced a Clavien-Dindo grade 3 complication within 30 d. Overall, PSMA-RGS identified two additional patients with high-risk PCa and pathologically node-positive (pN1) disease compared with preoperative PSMA PET, exhibiting a lower positive predictive value (PPV) and a similar negative predictive value (NPV) in the per-patient analysis (PPV: 50% vs 70%; NPV: 83% vs 83%). The PPV and NPV at per-region analysis in patients with molecular imaging node-positive (miN1) disease were higher for PSMA-RGS than for PSMA PET (PPV: 55% vs 42%; NPV: 85% vs 81%). In conclusion, PSMA-RGS identifies additional patients with pN1 disease missed by preoperative PSMA-PET among men with high-risk PCa, and extends the ePLND template in patients with miN1 disease, in whom PSMA PET underestimates the nodal burden. However, its NPV is suboptimal for avoiding ePLND in patients with PCa who have a LNI risk >5% and negative PSMA-RGS findings during RARP.
引用
- Quarta L, Zaurito P, Viti A, et al. PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study. Eur Urol. 2026. PMID: 42580956. doi:10.1016/j.eururo.2026.07.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。